NCT00002452View on ClinicalTrials.gov

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

L-756423

DRUG

Indinavir sulfate

Trial Locations (8)

10011

Cornell Clinical Trials Unit - Chelsea Clinic, New York

15261

Pittsburgh Treatment Ctr / Univ of Pittsburgh, Pittsburgh

20007

Georgetown Univ, Washington D.C.

30308

AIDS Research Consortium of Atlanta, Atlanta

37203

Vanderbilt Univ Med Ctr, Nashville

60612

The CORE Ctr, Chicago

96816

Hawaii AIDS Clinical Trial Unit, Honolulu

352942050

Univ of Alabama at Birmingham, Birmingham

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00002452 - A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir | Biotech Hunter | Biotech Hunter